−1.360SEK
−15.90 MSEK
6.44 M
About ONCOZENGE AB
Sector
CEO
Stian Kildal
Headquarters
Bromma
Website
Founded
2020
ISIN
SE0015504097
FIGI
BBG00Z3JSCX4
OncoZenge AB operates as a pharmaceutical company. The firm offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The compay was founded on June 15, 2020 and is headquartered in Bromma, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ONCOZ is 4.295 SEK — it has increased by 6.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ONCOZENGE AB stocks are traded under the ticker ONCOZ.
ONCOZ stock is 13.03% volatile and has beta coefficient of 3.42. Check out the list of the most volatile stocks — is ONCOZENGE AB there?
Yes, you can track ONCOZENGE AB financials in yearly and quarterly reports right on TradingView.
ONCOZ stock has risen by 10.13% compared to the previous week, the month change is a 28.59% rise, over the last year ONCOZENGE AB has showed a 54.74% decrease.
ONCOZ net income for the last quarter is −3.17 M SEK, while the quarter before that showed −4.19 M SEK of net income which accounts for 24.29% change. Track more ONCOZENGE AB financial stats to get the full picture.
Today ONCOZENGE AB has the market capitalization of 47.38 M, it has increased by 5.12% over the last week.
No, ONCOZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ONCOZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOZENGE AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCOZENGE AB technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCOZENGE AB stock shows the neutral signal. See more of ONCOZENGE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.